{"id":2487,"date":"2025-06-13T16:15:14","date_gmt":"2025-06-13T07:15:14","guid":{"rendered":"https:\/\/swanielle.medeta.co.jp\/?p=2487"},"modified":"2025-06-16T10:22:25","modified_gmt":"2025-06-16T01:22:25","slug":"%e8%bb%a2%e5%a3%b2%e3%82%b9%e3%82%a4%e3%83%83%e3%83%812%e3%82%92%e8%b2%b7%e3%81%86%e4%ba%ba%e3%81%af%e6%83%85%e5%a0%b1%e5%bc%b1%e8%80%85%ef%bc%9f%e3%80%80%e3%80%8c%e4%bf%9d%e8%a8%bc%e3%81%aa%e3%81%97","status":"publish","type":"post","link":"https:\/\/swanielle.com\/?p=2487","title":{"rendered":"New Initiative Launched to Combat Drug Loss and Support Overseas Biopharma Entry into Japan"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"2487\" class=\"elementor elementor-2487\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bcf1588 thegem-e-con-layout-thegem e-flex e-con-boxed e-con e-parent\" data-id=\"bcf1588\" data-element_type=\"container\" data-settings=\"{&quot;thegem_container_layout&quot;:&quot;thegem&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b6a69a0 flex-horizontal-align-default flex-horizontal-align-tablet-default flex-horizontal-align-mobile-default flex-vertical-align-default flex-vertical-align-tablet-default flex-vertical-align-mobile-default elementor-widget elementor-widget-heading\" data-id=\"b6a69a0\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">New Initiative Launched to Combat Drug Loss and Support Overseas Biopharma Entry into Japan\n \u2013 Jointly Led by Alfresa Holdings Corporation and Swanielle, Inc. \u2013\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-364002c thegem-e-con-layout-thegem e-flex e-con-boxed e-con e-parent\" data-id=\"364002c\" data-element_type=\"container\" data-settings=\"{&quot;thegem_container_layout&quot;:&quot;thegem&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5ec852d flex-horizontal-align-default flex-horizontal-align-tablet-default flex-horizontal-align-mobile-default flex-vertical-align-default flex-vertical-align-tablet-default flex-vertical-align-mobile-default elementor-widget elementor-widget-text-editor\" data-id=\"5ec852d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\">\r\n\t\t\t\t\t\t<p>June 16, 2025<br \/>Swanielle, Inc.<\/p><p>Swanielle, Inc. (Tokyo, Japan) is pleased to announce a new collaborative initiative with Alfresa Holdings Corporation aimed at addressing the growing issue of \u201cDrug Loss\u201d in Japan\u2014the phenomenon in which innovative therapies developed globally fail to reach Japanese patients due to delays or discontinuation in Japan-specific development.<br \/>\u00a0This initiative is specifically designed for emerging biopharmaceutical companies at intermediate development stages who are considering entering the Japanese market but face common barriers such as limited internal resources, regulatory complexity, or budget constraints.<br \/>\u00a0By combining Alfresa\u2019s extensive healthcare infrastructure with Swanielle\u2019s deep expertise in Japan-focused development, the initiative offers a streamlined, resource-supported pathway for global innovators to evaluate or pursue clinical and commercial presence in Japan.<br \/>\u00a0Through this collaboration, Alfresa and Swanielle aim not only to support overseas biopharma companies but also to reduce Drug Loss and help deliver needed treatments to Japanese patients in a timely manner.<\/p><p>For inquiries:<br \/>Hiroshi Yamabe, CEO, Swanielle, Inc.<br \/><a href=\"https:\/\/swanielle.com\/?page_id=19\">contact form<\/a><\/p>\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>New Initiative Launched to Combat Drug Loss and Support Overseas Biopharma Entry into Japan \u2013 Jointly Led by Alfresa Holdings&#8230;<\/p>\n","protected":false},"author":1,"featured_media":1909,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-fullwidth.php","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2487","post","type-post","status-publish","format-standard","has-post-thumbnail","category-uncategorized"],"menu_order":0,"_links":{"self":[{"href":"https:\/\/swanielle.com\/index.php?rest_route=\/wp\/v2\/posts\/2487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/swanielle.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/swanielle.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/swanielle.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/swanielle.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2487"}],"version-history":[{"count":17,"href":"https:\/\/swanielle.com\/index.php?rest_route=\/wp\/v2\/posts\/2487\/revisions"}],"predecessor-version":[{"id":2515,"href":"https:\/\/swanielle.com\/index.php?rest_route=\/wp\/v2\/posts\/2487\/revisions\/2515"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/swanielle.com\/index.php?rest_route=\/wp\/v2\/media\/1909"}],"wp:attachment":[{"href":"https:\/\/swanielle.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/swanielle.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/swanielle.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}